There is convincing evidence that the prevalence of erectile dysfunction is increased among men with ischaemic heart disease. This association may be attributed to the fact that both erectile dysfunction and ischaemic heart disease share similar risk factors (e.g. hypertension, dyslipidaemia, diabetes and smoking). Nitric oxide (NO) activity is adversely affected, in penile and vascular tissue, by these risk factors. It is therefore not surprising that a defect in NO activity is thought to play a role in the pathogenesis of both erectile dysfunction and ischaemic heart disease. We consider this evidence and propose that defective NO activity provides a unifying explanation for the association between these two conditions. Further research in this area may improve our understanding of the pathogenesis of cardiovascular diseases as a whole.
Introduction
of erectile dysfunction. We also consider that this association may relate to the fact that the same risk factors (e.g. Penile erection is a haemodynamic process, involving hypertension, dyslipidaemia, diabetes and smoking) predict increased arterial inflow and restricted venous outflow, both erectile dysfunction and vascular disease. coordinated with corpus cavernosum smooth muscle relax-
The association between erectile dysfunction and isation [1] . Although this process is generally accepted to be chaemic heart disease raises the important question of under neuroregulatory control [1-13], biochemical mediwhether vasculogenic erectile dysfunction is yet another ators released locally from the endothelium and / or smooth manifestation of atherosclerosis. Impaired NO activity may muscle also participate in initiating and maintaining erecprovide a unifying explanation for such an association. tion [14] [15] [16] . Nitric oxide (NO), which is produced both in cavernosal nerves and endothelium, has recently been recognized to play a key role in the physiology of penile 2. NO and penile erectile physiology erection [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
In this review we consider the evidence showing that There is convincing evidence that during erection the men with ischaemic heart disease have a high prevalence local release of NO and / or related factors produces relaxation of the corpus cavernosum [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Nonadrener-*Corresponding author. Tel.: 144-171-7940-500 (Ext. 3481); fax: 144-171-7949-537.
Time for primary review 36 days.
gic, noncholinergic (NANC) nerve-mediated NO release in the adventitia of the deep cavernous arteries. Keast [19] , appears to be the most important with respect to cavernosal using nicotinamide adenine dinucleotide phosphate smooth muscle relaxation [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] (Fig. 1) . However, the (NADPH) diaphorase staining to demonstrate NOS in the erectile process may, at least in part, be acetylcholine rat penis, found the enzyme both in endothelial cells lining (ACh)-mediated in the human and rabbit corpus cavermany blood vessels and within the cavernous spaces. nosum [14] [15] [16] .
The NOS demonstrated in rat and rabbit corpus caverThe innervation of the corpus cavernosum and the nosum was shown to display substantial activity, as 3 3 endothelium may both be sources of NO. Using an antimonitored by the ability to convert [ H]-arginine to [ H]-serum to the constitutive NO synthase (NOS) found in rat citrulline [18, 20] . In rabbit corpus cavernosum, the enzyme cerebellum, Burnett et al. [16] demonstrated staining of the present was a cytosolic constitutive isoform of NOS [20] , pelvic plexus and the axonal processes forming the cavernsimilar to that found in brain neuronal tissue. The endoous nerve. The nerve plexus of the adventitia of the deep thelium-derived NOS (eNOS) is primarily membranecavernosal arteries and the neuronal processes in the bound [21] . This suggests that the most important source sinusoids and the periphery of the corpora cavernosa were of NO in penile tissue is neuronal.
G prominently stained. Dorsal penile and cavernosal arteries Analogues of L-arginine, like N -monomethyl-L-ar-G stained for NOS both in the adventitial and endothelial ginine (L-NMMA) and N -nitro-L-arginine methyl ester layers, although endothelial staining was faint in the (L-NAME), effectively inhibit NOS. In vitro, these agents cavernosal vessels. Alm et al.
[17] using antiserum proinhibit the relaxation of cavernous tissue caused by electriduced in rabbits against a COOH-terminal fragment of the cal field stimulation (EFS) and muscarinic receptor stimurat cerebellar NOS, confirmed these findings. NOS was lation [2-4,6,9,11,13]. This inhibitory effect was partially also identified [18] in the cavernous nerves and their counteracted by exogenous L-arginine.
G
terminal endings within the corpora cavernosa, in the N -nitro-L-arginine (L-NA) augmented the contractions branches of the dorsal penile nerves and in nerve plexuses induced by noradrenaline but had little effect on resting corpus cavernosum regulate the activity of cGMP [26, 27] . NO production, but not the ability of the smooth muscle Experimental studies have shown that both PDE III and V to respond to NO, seems dependent on the oxygen tension isoenzymes play an important role in cavernosal smooth [22, 23] . Electrically-induced relaxations were progressivemuscle tone [26, 27] . The inhibition of PDE V activity ly inhibited as a function of decreasing oxygen tension forms the basis of treating ED with sildenafil [26, 27] [31] . This has advantages ing the view that neuronally-released NO acts by stimulaover pharmacological inhibition of NOS activity, because tion of soluble guanylate cyclase activity.
it allows the study of the NOS enzyme independent of In rats, the intracavernous injection of drugs that act on other NOS enzymes. These transgenic mice are viable and the adenosine-3959-cyclic monophosphate (cAMP) and appear to preserve erectile function [31] , suggesting the cGMP pathways revealed that neither cAMP nor drugs that collaborative or compensatory effects of other sources of stimulate adenylate cyclase activity induced any change in NO and / or other mediators. Another explanation for these intracavernosal pressure [25] . In contrast, the intracaverfindings is that these transgenic mice retain an allele for nosal injection of cGMP and SNP caused dose-dependent neuronal NOS, nNOSb [32] . The neuronal distributions of changes in intracavernous pressure that could be inhibited the penis in these mice were shown to retain nNOS protein by methylene blue (a guanylate cyclase inhibitor). It was and mRNA, with nNOSb expression demonstrable in these therefore concluded that cavernous smooth muscle relaxastructures [32] . The validity of this knockout model is thus tion in the rat is mediated by activation of guanylate open to question. Similar disruption of the eNOS gene has cyclase and that the cAMP system only plays a minimal resulted in mice which are aggressive, fertile and resistent role [25] .
to the development of atherosclerosis [33] . These studies In vitro results obtained from isolated penile tissue strips did not specifically demonstrate erectile dysfunction or suggest that the local neuronal L-arginine / NO system is normal erectile function in these transgenic eNOS mice essential for normal erection. There is accumulating in [33] . The findings, however, suggest that eNOS does not vivo data to support this view. In anaesthetized rabbits, play a major role in the synthesis of NO involved in erections induced by stimulation of the cavernous nerves cavernosal smooth muscle relaxation or that alternative could be dose-dependently inhibited by the intracorporeal sources of NO and / or other mediators of penile erection injection of L-NA (an inhibitor of NOS activity) [5] . In can compensate for the loss of the eNOS enzyme. NOS anaesthetized rats, intravenous L-NA inhibited erection localized to the vascular and sinusoidal endothelium of induced by the stimulation of the cavernous nerves [16] .
penises of normal animals and neuronal NOS-deficient Therefore, there is convincing experimental evidence for mice has been demonstrated by immunolocalisation studies the assumption that neurogenic NO is an important medi- [34] . Inducible NOS has also been shown to be expressed ator of penile erection.
on rat corporeal smooth muscle cells [35] suggesting that To date, the majority of studies support the concept that these cells can generate NO. To what extent these isoforms NO derived from the autonomic innervation of the penis participate in normal erectile function awaits further operates locally as a post-ganglionic neurotransmitter of clarification. NANC-mediated penile erection [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 20, [24] [25] [26] [27] [28] [29] [30] . FollowSeveral studies have assessed the role of androgens on ing its synthesis and release from nerve terminals, NO the penile NO pathway. Androgen deprivation reduces activates guanylate cyclase in vascular and trabecular NOS content, activity and erectile responses in the rat penis [36] . Furthermore, its replacement in castrated rats heart disease and erectile dysfunction [46] . This topic is restores these effects [37] . These restorative effects were discussed in detail in the sections below. attributed to dihydrotestosterone as the active androgen [38] . Plasma androgen levels also affect NOS activity 3.4. Aging assayed in electrically stimulated erect rat penises [39] .
Increasing age correlates with altered NO synthesis and erectile responses in the rat penis [50] . This could be one explanation for the increasing incidence of erectile 3. NO and the predictors of erectile dysfunction dysfunction with aging in man [50].
3.1. Diabetes mellitus (DM) 3.5. Radiation effects DM represents one of the major organic causes of Radiation has been shown to reduce the number of erectile dysfunction, with as many as 50% of men with penile NOS containing nerves in the rat, possibly pro-DM suffering from erectile dysfunction [40] . It is also well viding an explanation for the development of erectile established that DM is associated with an increased dysfunction in man, post-pelvic irradiation [51] . incidence of vascular events. A link between the pathogenesis of erectile dysfunction and decreased local NO activity was suggested because in isolated corpus caver-4. Clinical applications nosum strips from diabetic patients with ED, both neurogenic and endothelium-dependent relaxations were imInitial attempts to utilize the NO pathway therapeutically paired [41] . Similar findings were also apparent in alloxaninvolved the intracavernous administration of the NO induced DM rabbits [42] . Reduced relaxation to EFS in donor, linsidomine chlorohydrate (SIN-1), a drug that cavernosal tissue taken from diabetic patients with erectile releases NO non-enzymatically [52, 53] . These clinical dysfunction has also been demonstrated [43] . This was studies [52, 53] showed that SIN-1 can elicit erection, but associated with a lack of NO production (measured as the the overall response rates are inferior to other intracaverformation of nitrite) and not to the inability of the smooth nosal agents in current use, such as prostaglandin E and 1 muscle to relax [43] . Further insight into the mechanisms its analogues. SIN-1 injections did not produce any local involved was provided by studies which showed a signifidiscomfort or inflammatory and fibrotic reactions, supportcant increase in NOS binding sites (putative receptors) in ing the interpretation that its mode of action is physiologirat cavernosum two months post-induction of DM [44] .
cal. More recently, sildenafil, an orally active type V PDE This finding suggests that an impairment in NO bioavailinhibitor, has shown response rates comparable to inability, either due to a lack of the substrate L-arginine, due tracavernosal agents [54, 55] . Not surprisingly, this has had to NO quenching (e.g. by advanced glycosylation enda major impact on the management of erectile dysfunction. products (AGE'S)) [45] or via inactivation by superoxide plays a role in the pathogenesis of erectile dysfunction associated with DM.
5. Erectile dysfunction and ischaemic heart disease: does defective NO activity contribute to the 3.2. Hypercholesterolaemia pathogenesis of both conditions?
As mentioned above hypercholesterolaemia is a recogAs discussed above, numerous studies have shown that nized risk factor for both vasculogenic erectile dysfunction ischaemic heart disease and erectile dysfunction share [46, 47] and ischaemic heart disease. Studies using a common risk factors [46, 47] . More recently, preliminary genetic rabbit model of hypercholesterolaemia suggest that studies suggest that fibrinogen [56] and lipoprotein (a) (our this lipid abnormality may account for erectile dysfunction unpublished results) are risk factors for erectile dysfunction because of changes in penile endothelin receptor disas well as for ischaemic heart disease. Epidemiologically, tribution. These changes may, in turn, influence NOSthe long-term follow up of the Massachusetts Male Aging dependent mechanisms [48] . Experiments using cholesstudy concluded that the risk of moderate or complete terol-fed rabbits have demonstrated that the inhibition of erectile dysfunction in patients with cardiovascular risk NO synthesis promotes the development of atheroma-like factors was 31% (higher than in an age-matched diseaselesions, whereas supplementation with L-arginine prevents free control cohort: 19.6%) [46] . It may also be relevant these changes [49] .
that the risk factors for ischaemic heart disease and erectile dysfunction behave synergistically in both conditions.
Hypertension
However, of equal interest are studies that show that the extent of ischaemic heart disease is related to the risk of Hypertension is also associated with both ischaemic concomitant erectile dysfunction. Thus, two studies have shown a significant correlation between the presence of arteries [66] and canine superficial temporal arteries [67] , vasculogenic erectile dysfunction and clinically evident / supporting a regulatory role in these vascular beds. subclinical ischaemic heart disease [57, 58] . For example, Decreased endothelium-dependent relaxation of isolated Greenstein et al. [57] reported a significant correlation blood vessels has been described in experimental animal between erectile dysfunction and the number of coronary models of systemic and pulmonary hypertension [68] . vessels occluded on angiography. Anderson et al. [58] These findings have been ascribed to either an attenuation showed that patients with severe arteriogenic erectile of NO activity or augmented elaboration of an endodysfunction (assessed by duplex sonography) had a 16% thelium-derived contracting factor. More definitive data for risk of suffering from severe, although asymptomatic, a primary role of NO in the regulation of blood pressure ischaemic heart disease.
has been shown in a mouse model with inactivation of the Alterations in the endothelial L-arginine-NO pathway eNOS gene [33] . This impairment of endothelial NO have been demonstrated in both atherosclerotic and hybioavailability could be one explanation why hypertension percholesterolaemic coronary arteries of humans and aniis a risk factor for vasculogenic erectile dysfunction [46] . mal models [59] [60] [61] [62] [63] . These studies support the concept Obviously, hypertension-related erectile dysfunction could that there is a reduction in NO bioavailability in these also result from the use of certain antihypertensive agents conditions. These findings are similar to those seen in the (e.g. thiazides or b-blockers). penile L-arginine-NO pathway and would support the Another link between erectile dysfunction and ischaemic concept that vasculogenic changes in the penile vascular heart disease or DM is the raised circulating levels of bed in erectile dysfunction mirror those in the coronary endothelin-1 (ET-1) [69] [70] [71] . This peptide belongs to a arteries.
family of potent vasoconstrictors. To date, two major ET The role of NANC-mediated NO release in the coronary receptors have been identified and cloned: ET and ET A B circulation is unclear, though NANC nerves have been [72] . ET is considered a physiological antagonist of NO implicated in coronary blood flow regulation [64] . Other [73, 74] (Fig. 2) . Several studies have indicated the poworkers have found that NANC-mediated NO production tential importance of ET-1 in the modulation of corpus vasodilates human cerebral arteries [65] , bovine basilar cavernosum smooth muscle tone [69, 75, 76] . Studies have suggested that ET-1 may have a role in the development of achieves this by inhibiting the hydrolysis of cGMP, hypertension [77, 78] and DM [79] , both of which are produced via the L-arginine-NO pathway. cardiovascular risk factors that are also associated with Further research in this area is needed to determine the erectile dysfunction [40] [41] [42] [43] [44] [45] [46] 80] . The link between hyprecise pathophysiological role of NO in this organ. This pertension and erectile dysfunction is illustrated by abnorwork may also provide further insights into the pathomal penile vascular responses, as shown by dynamic genesis of cardiovascular diseases as a whole. testing (e.g. using papaverine and Duplex sonography) [80] . Hypertension acts synergistically with other vascular risk factors (e.g. DM and smoking) in terms of increasing References the probability of erectile dysfunction [80] . Moreover, the plasma levels of ET-1 are higher in diabetics with erectile Erectile dysfunction and ischaemic heart disease may 
Conclusions

